GENMAB A/S - 12 Dec 2025 SCHEDULE 13D Report for Merus N.V. Common Shares, Euro 0.09 nominal value per share (MRUS)

Filing Manager
GENMAB A/S
Reporting Manager
Genmab A/S
Security
Merus N.V. Common Shares, Euro 0.09 nominal value per share
Symbol
MRUS
Shares outstanding
75.9M shares
Disclosed Ownership
71.9M shares
Ownership
94.8%
Form type
SCHEDULE 13D
Filing time
19 Dec 2025, 12:32:00 UTC
Date of event
12 Dec 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Genmab A/S 94.8% 71.9M 0 71.9M /s/ Jan G. J. van de Winkel Jan G. J. van de Winkel, President & Chief Executive Officer 0001434265
Genmab Holding II B.V. 94.8% 71.9M 0 71.9M /s/ Jan G. J. van de Winkel Jan G. J. van de Winkel, Authorized Signatory